UNSPSC 51144303: Phendimetrazine tartrate

This classification denotes a cns stimulant and anorexiant with the molecular formula C12H17NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6985IP0T80, chemically known as morpholine, 3,4-dimethyl-2-phenyl-, tartrate, d- but more generally known as phendimetrazine tartrate, which bears US NIH Compound Identifier 120608. European Medicines Agency schedules Phendimetrazine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03739MIG.

UNSPSC 51144303 Phendimetrazine tartrate is a Commodity code that nominally covers a specific pharmaceutical weight-loss medication, but recent state and local procurement activity under this code does not align with that scope. The single recent opportunity in the database — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and safe drug deactivation systems for community health support, a mismatch with the code's stated pharmaceutical commodity. State and local buying under this code shows little relevant recent activity that corresponds to the phendimetrazine tartrate classification.

Seminole County posted the naloxone and drug deactivation systems IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The contract includes a two-year initial term with a one-year renewal option, and bidders must comply with drug-free workplace certification, E-Verify requirements, and potential FEMA-related federal compliance obligations. The procurement does not specify set-aside designations for disadvantaged enterprises, and vendors are responsible for all shipping and delivery costs included in their bids.